Product Overview

Trelegy Ellipta Powder for Inhalation is a prescription combination inhaler containing Fluticasone Furoate, Umeclidinium, and Vilanterol. It is used as a long-term maintenance treatment for adults with chronic obstructive pulmonary disease (COPD). Fluticasone Furoate is an inhaled corticosteroid that helps reduce inflammation in the airways, while Umeclidinium and Vilanterol are long-acting bronchodilators that help relax the airway muscles and improve airflow. Regular use may help control symptoms such as shortness of breath, wheezing, coughing, and chest tightness associated with COPD. Trelegy Ellipta is intended for regular daily use as prescribed by a healthcare professional and is not designed to provide immediate relief during a sudden breathing problem or acute bronchospasm. Patients should follow the prescribed dosage and inhalation technique carefully. It is important to inform the healthcare professional about existing medical conditions and all other medicines being taken before starting treatment. Rinsing the mouth with water after inhalation and spitting the water out may help reduce the risk of oral fungal infections. Trelegy Ellipta should be used only under appropriate medical supervision, particularly in patients with cardiovascular conditions, glaucoma, urinary retention, diabetes, osteoporosis, or other relevant medical conditions.

Precautions

Trelegy Ellipta is not a rescue inhaler and should not be used for sudden breathing difficulties.
Use a prescribed rescue inhaler for acute symptoms as directed.
Rinse your mouth after each dose and spit out the water.
Tell your doctor if you have heart disease, high blood pressure, glaucoma, urinary retention, diabetes, osteoporosis, seizures, or thyroid problems.
Inform your healthcare professional about any allergies to its ingredients.
Seek medical attention if breathing suddenly becomes worse after inhalation.
Use during pregnancy or breastfeeding only after discussing the potential benefits and risks with a healthcare professional.

Usage

Use Trelegy Ellipta once daily, at the same time each day, or as prescribed by your doctor.
Inhale the medicine through the Ellipta inhaler exactly as instructed.
Do not take more than the prescribed dose.
Use it regularly even when you are feeling well, unless your doctor advises otherwise.
Do not use Trelegy Ellipta for sudden breathing problems; use your prescribed rescue inhaler instead.
Rinse your mouth with water after inhalation and spit it out to help reduce the risk of oral thrush.
Do not share your inhaler with another person.
If you miss a dose, take it when you remember unless it is nearly time for your next dose. Do not take two doses on the same day.

Uses

Long-term maintenance treatment of COPD
Helps improve airflow
Helps control coughing, wheezing, and shortness of breath
Helps maintain better respiratory control when used regularly

Side Effects

Headache
Sore throat
Cough
Hoarseness
Dry mouth
Upper respiratory tract infection
Oral thrush

FAQs

1. What is Trelegy Ellipta used for?
It is used as a maintenance treatment for COPD and helps control respiratory symptoms and improve airflow.

2. Is Trelegy Ellipta a rescue inhaler?
No. It is a maintenance inhaler and is not intended to provide immediate relief from sudden breathing problems.

3. How often is Trelegy Ellipta used?
It is generally used once daily, as prescribed by a healthcare professional.

4. Should I rinse my mouth after using Trelegy Ellipta?
Yes. Rinsing your mouth and spitting out the water after inhalation can help reduce the risk of oral thrush.

5. Can Trelegy Ellipta be used with other inhalers?
Some patients may need other inhalers, but this should be determined by a healthcare professional because combining similar medicines can increase the risk of side effects.

6. Can I stop using Trelegy Ellipta when I feel better?
Do not stop or change your treatment without consulting your healthcare professional.

Interactions

May interact with beta-blockers, which can reduce the effect of vilanterol.
Other long-acting bronchodilators should generally not be used together unless specifically prescribed.
Diuretics may increase the risk of low potassium levels.
MAO inhibitors and tricyclic antidepressants may increase cardiovascular effects.
Strong CYP3A4 inhibitors such as ketoconazole and ritonavir may increase exposure to fluticasone furoate and vilanterol.
Other corticosteroids may increase the risk of corticosteroid-related side effects.
Tell your doctor about all prescription medicines, OTC medicines, vitamins, and supplements you take.